Gramine

Gramine is a naturally occurring indole alkaloid found primarily in barley (Hordeum vulgare) and other grasses, where it functions as a plant defense compound. It acts on monoamine-related pathways due to its structural similarity to tryptamine, though no confirmed therapeutic applications in humans have been established.

Origin & History

Gramine is an indole alkaloid (3-(dimethylaminomethyl)indole) first isolated in 1935 from Arundo donax L. (giant reed) and found in other plants including silver maple, lupinus seeds, and barley cultivars (up to 8 mg/g dry weight). It is extracted using ultrasonic methods from A. donax (1% yield) or synthesized via Mannich reaction with yields of 70-98%.

Historical & Cultural Context

No historical or traditional medicinal uses of gramine are documented in the sources. It is primarily noted for modern discovery (1935 onward) and phytochemical research rather than ethnomedical contexts.

Health Benefits

• No health benefits documented - no human clinical trials identified in available research
• Toxicity studies conducted only in Wistar rats with unspecified outcomes
• No evidence of therapeutic effects in humans
• No traditional medicinal uses documented
• Research limited to extraction and synthesis methods only

How It Works

Gramine (3-(dimethylaminomethyl)indole) shares structural homology with tryptamine and serotonin, suggesting potential interaction with serotonergic and adrenergic receptors, though no confirmed receptor-binding studies in humans exist. In vitro studies indicate it may inhibit monoamine oxidase (MAO) activity and interfere with cellular transport mechanisms, particularly affecting amino acid uptake across membranes. Its cytotoxic effects observed in cell studies are hypothesized to involve disruption of mitochondrial membrane potential, though the precise molecular cascade remains uncharacterized.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for gramine were identified in the available sources. Research is limited to preclinical extraction, synthesis, and toxicity studies in animals, with no PubMed PMIDs for human studies provided.

Clinical Summary

As of available literature, no human clinical trials investigating gramine's therapeutic effects have been identified or published. Toxicity data is limited to rodent studies, specifically Wistar rat models, with outcomes and dosing thresholds not fully disclosed in accessible research. In vitro studies have examined gramine's cytotoxic and antimicrobial properties, but these findings have not been translated into human safety or efficacy data. The overall evidence base is preclinical and insufficient to support any health claims.

Nutritional Profile

Gramine (3-(dimethylaminomethyl)indole) is a naturally occurring indole alkaloid, not a nutritional ingredient. It contains no macronutrients (zero caloric value as a pure compound), no dietary fiber, no vitamins, and no essential minerals in its isolated form. As a bioactive compound, gramine is found endogenously in barley (Hordeum vulgare) at concentrations ranging approximately 0.1–0.5% dry weight in young seedlings, and in reed canary grass (Phalaris arundinacea) at concentrations up to 0.2% dry weight. Chemically, it has a molecular weight of 174.24 g/mol and contains a dimethylaminomethyl side chain attached to an indole ring system, giving it structural similarity to tryptamine derivatives. It acts as a serotonin receptor antagonist and acetylcholinesterase inhibitor in laboratory contexts. Bioavailability in biological systems is documented in Wistar rat toxicity studies, indicating it is absorbed systemically, but human pharmacokinetic data (absorption rate, metabolism pathway specifics, elimination half-life) are not established. No nutritional contribution to human diet has been documented. Its presence in barley-based foods is incidental and at trace levels well below isolated compound concentrations used in research settings.

Preparation & Dosage

No clinically studied dosage ranges or forms are available as human trials are absent. Only extraction yields (1% from A. donax) and synthesis yields (70-98%) have been documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Gramine is considered potentially toxic based on animal and in vitro data; it has demonstrated cytotoxic activity in cell models, raising concern about safe human dosing thresholds. No established safe dose for human consumption exists, and no formal drug interaction studies have been conducted. Given its structural similarity to tryptamine and potential MAO-inhibiting properties, theoretical interactions with serotonergic drugs, MAO inhibitors, and antidepressants cannot be ruled out. Gramine should be avoided during pregnancy and breastfeeding due to a complete absence of safety data in these populations.